| Date | Time | Source | Headline | Symbol | Company |
| 02/14/2011 | 4:24PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/14/2011 | 1:45PM | Edgar (US Regulatory) | Schedule 13G | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/08/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/07/2011 | 6:26PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/07/2011 | 6:26PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/01/2011 | 6:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2011 | 10:58AM | Dow Jones News | 2nd UPDATE: Eli Lilly 4Q Profit Jumps 28% On Better Revenue, Margins | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/26/2011 | 4:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/26/2011 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports 2010 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/19/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Year-End Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/18/2011 | 6:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/11/2011 | 4:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/10/2011 | 4:35PM | PR Newswire (US) | Amylin to Advance Key Value-Driving Opportunities in 2011 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/07/2011 | 7:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/07/2011 | 7:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/07/2011 | 7:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/03/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/30/2010 | 5:22PM | Dow Jones News | Approvals Of New Drugs Down In 2010 Vs 2009, 2008 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/22/2010 | 5:56PM | Dow Jones News | Amylin, Eli Lilly Seek Wider Approval Of Diabetes Drug Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/22/2010 | 4:15PM | PR Newswire (US) | Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/20/2010 | 2:26PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/20/2010 | 8:00AM | PR Newswire (US) | Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/22/2010 | 6:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/19/2010 | 8:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/17/2010 | 10:30AM | PR Newswire (US) | Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compa | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/16/2010 | 8:00AM | PR Newswire (US) | Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals Partner to Investigate Metreleptin as Potential Therapy to Impr | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/09/2010 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Citi 7th Annual US Small/Mid Cap Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/08/2010 | 4:08PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/04/2010 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/04/2010 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |